Clinical trial
Phase I Study of Intrathecal Topotecan
NCT00001333 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study of Intrathecal Topotecan
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 1993
- Completion date
- December 31, 2000
- Enrollment
- 30
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.